Pre-existing depression predicts survival in cardiovascular disease and cancer

Journal of Epidemiology and Community Health
Lei YangPekka Martikainen

Abstract

Previous studies have found depression to be negatively associated with the prognosis of both cardiovascular disease (CVD) and cancer, but this may partly reflect reverse causality. We limited the possibility of reverse causality by measuring depression before the first diagnosis of CVD or cancer. We used an 11% longitudinal random sample of the Finnish population aged 25 years or older who are residents of Finland for at least 1 year between 1987 and 2007, with an 80% oversample of those who died during this period. Those who had their first incidence of coronary heart disease (CHD) (n=107 966), stroke (n=68 685) or cancer (n=113 754) between 1998 and 2012 were followed up for cause-specific mortality from the date of diagnosis until the end of 2012. Depression was defined as having antidepressant purchases two to three calendar years before the incidence. Logistic and Cox regression models were used to examine short-term and long-term mortality by depression status. Long-term mortality after diagnosis was 1.34 (95% CI 1.25 to 1.44) for CHD, 1.26 (95% CI 1.15 to 1.37) for stroke and 1.10 (95% CI 1.04 to 1.16) for cancer in those who had used antidepressants in two consecutive calendar years as compared with those with no purch...Continue Reading

References

Sep 1, 1989·JAMA : the Journal of the American Medical Association·A B ZondermanR R McCrae
May 30, 1998·Archives of Internal Medicine·S A EversonG A Kaplan
Mar 20, 2001·Archives of General Psychiatry·B W PenninxW van Tilburg
Dec 4, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M JoukamaaV Lehtinen
Jul 29, 2003·Psychosomatic Medicine·Kirk W BrownLinda Edgar
Aug 29, 2003·Lancet·James A BlumenthalUNKNOWN NORG Investigators
Nov 14, 2003·European Heart Journal·H LuukinenH V Huikuri
Dec 1, 2004·Stroke; a Journal of Cerebral Circulation·Brooks B GumpUNKNOWN MRFIT Research Group
Apr 1, 2006·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Marjolein H KamphuisDaan Kromhout
Nov 30, 2006·International Journal of Geriatric Psychiatry·Merja AhtoSirkka-Liisa Kivelä
Aug 23, 2007·European Journal of Clinical Pharmacology·Jari HaukkaJouko Lönnqvist
May 22, 2008·Nature Clinical Practice. Oncology·Yoichi ChidaAndrew Steptoe
Feb 24, 2009·Journal of Psychosomatic Research·Mark HamerGerard J Molloy
Jun 6, 2009·International Journal of Cardiology·Lynn V DoeringKathleen Dracup
Jan 21, 2010·Psychological Medicine·M Pinquart, P R Duberstein
Apr 21, 2011·Circulation. Cardiovascular Quality and Outcomes·Tené T LewisSusan A Everson-Rose
Jun 27, 2012·Nature Reviews. Cardiology·Charles B Nemeroff, Pascal J Goldschmidt-Clermont
Mar 30, 2013·Journal of the American Heart Association·Lana L WatkinsMichael H Sketch
Apr 1, 2014·Journal of Affective Disorders·Lynn BoschlooBrenda W J H Penninx
Apr 6, 2016·Frontiers in Psychiatry·Arup K Dhar, David A Barton
Jun 24, 2016·European Journal of Public Health·Heta MoustgaardPekka Martikainen
Aug 16, 2016·European Heart Journal·Nick TownsendMelanie Nichols
Jan 23, 2017·Oral Oncology·Katherine RiekeShinobu Watanabe-Galloway
Mar 4, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Jens SundbøllHenrik Toft Sørensen

❮ Previous
Next ❯

Citations

Sep 6, 2018·Food & Function·Carine Smith, Amanda Swart
Feb 17, 2021·The Canadian Journal of Cardiology·Paul J ConnellyValeria Raparelli
May 4, 2021·Psychosomatic Medicine·Jane WalkerMichael Sharpe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.